248 related articles for article (PubMed ID: 22187609)
1. Virological profile of pregnant HIV positive women with high levels of CD4 count in low income settings: can viral load help as eligibility criteria for maternal triple ARV prophylaxis (WHO 2010 option B)?
Njom Nlend AE; Same Ekobo C; Moyo ST; Nguetcheng GC; Ngang P; Lyeb S; Meka L; Baane M
Pan Afr Med J; 2011; 10():27. PubMed ID: 22187609
[TBL] [Abstract][Full Text] [Related]
2. Short-term antiretroviral therapy to prevent mother-to-child transmission is safe and results in a sustained increase in CD4 T-cell counts in HIV-1-infected mothers.
Palacios R; Senise J; Vaz M; Diaz R; Castelo A
HIV Med; 2009 Mar; 10(3):157-62. PubMed ID: 19245537
[TBL] [Abstract][Full Text] [Related]
3. Pregnancy Profile and Infant Outcomes Among HIV Infected Women Who Delivered in Cipto Mangunkusumo Hospital.
Indarti J; Yunihastuti E; Kurniati N; Aprilia B; Pamungkas DT; Chiprion AT; Ginting MA; Rizal S; Dewi C; Handayani L
Acta Med Indones; 2020 Jan; 52(1):55-62. PubMed ID: 32291372
[TBL] [Abstract][Full Text] [Related]
4. Maternal HIV-1 disease progression 18-24 months postdelivery according to antiretroviral prophylaxis regimen (triple-antiretroviral prophylaxis during pregnancy and breastfeeding vs zidovudine/single-dose nevirapine prophylaxis): The Kesho Bora randomized controlled trial.
Kesho Bora Study Group
Clin Infect Dis; 2012 Aug; 55(3):449-60. PubMed ID: 22573845
[TBL] [Abstract][Full Text] [Related]
5. Evidence for extended age dependent maternal immunity in infected children: mother to child transmission of HIV infection and potential interventions including sulfatides of the human fetal adnexa and complementary or alternative medicines.
Bhargav H; Huilgol V; Metri K; Sundell IB; Tripathi S; Ramagouda N; Jadhav M; Raghuram N; Ramarao NH; Koka PS
J Stem Cells; 2012; 7(3):127-53. PubMed ID: 23619381
[TBL] [Abstract][Full Text] [Related]
6. Management of human immunodeficiency virus-infected pregnant women at Latin American and Caribbean sites.
Read JS; Cahn P; Losso M; Pinto J; Joao E; Duarte G; Cardoso E; Freimanis-Hance L; Stoszek SK;
Obstet Gynecol; 2007 Jun; 109(6):1358-67. PubMed ID: 17540808
[TBL] [Abstract][Full Text] [Related]
7. Antiretroviral therapy (ART) for treating HIV infection in ART-eligible pregnant women.
Sturt AS; Dokubo EK; Sint TT
Cochrane Database Syst Rev; 2010 Mar; (3):CD008440. PubMed ID: 20238370
[TBL] [Abstract][Full Text] [Related]
8. Women's preferences regarding infant or maternal antiretroviral prophylaxis for prevention of mother-to-child transmission of HIV during breastfeeding and their views on Option B+ in Dar es Salaam, Tanzania.
Ngarina M; Tarimo EA; Naburi H; Kilewo C; Mwanyika-Sando M; Chalamilla G; Biberfeld G; Ekstrom AM
PLoS One; 2014; 9(1):e85310. PubMed ID: 24465532
[TBL] [Abstract][Full Text] [Related]
9. Safety of nevirapine-containing antiretroviral triple therapy regimens to prevent vertical transmission in an African cohort of HIV-1-infected pregnant women.
Marazzi MC; Germano P; Liotta G; Guidotti G; Loureiro S; da Cruz Gomes A; Valls Blazquez MC; Narciso P; Perno CF; Mancinelli S; Palombi L
HIV Med; 2006 Jul; 7(5):338-44. PubMed ID: 16945080
[TBL] [Abstract][Full Text] [Related]
10. Time to viral load suppression in antiretroviral-naive and -experienced HIV-infected pregnant women on highly active antiretroviral therapy: implications for pregnant women presenting late in gestation.
Aziz N; Sokoloff A; Kornak J; Leva NV; Mendiola ML; Levison J; Feakins C; Shannon M; Cohan D
BJOG; 2013 Nov; 120(12):1534-47. PubMed ID: 23924192
[TBL] [Abstract][Full Text] [Related]
11. Maternal HIV-1 DNA load and mother-to-child transmission.
Arvold ND; Ngo-Giang-Huong N; McIntosh K; Suraseranivong V; Warachit B; Piyaworawong S; Changchit T; Lallemant M; Jourdain G;
AIDS Patient Care STDS; 2007 Sep; 21(9):638-43. PubMed ID: 17919090
[TBL] [Abstract][Full Text] [Related]
12. HIV-1 infection and pregnancy in young women in Brazil: socioeconomic and drug resistance profiles in a cross-sectional study.
Lima YA; Reis MN; Cardoso LP; Stefani MM
BMJ Open; 2016 Jul; 6(7):e010837. PubMed ID: 27381205
[TBL] [Abstract][Full Text] [Related]
13. [Factors associated with virological response in women receiving highly-active antiretroviral prophylaxis for HIV-1 mother-to-child transmission].
Palacios R; Senise JF; Vaz MJ; Castelo A
Enferm Infecc Microbiol Clin; 2008; 26(7):411-5. PubMed ID: 18842235
[TBL] [Abstract][Full Text] [Related]
14. Comparing two service delivery models for the prevention of mother-to-child transmission (PMTCT) of HIV during transition from single-dose nevirapine to multi-drug antiretroviral regimens.
Tsague L; Tsiouris FO; Carter RJ; Mugisha V; Tene G; Nyankesha E; Koblavi-Deme S; Mugwaneza P; Kayirangwa E; Sahabo R; Abrams EJ
BMC Public Health; 2010 Dec; 10():753. PubMed ID: 21134259
[TBL] [Abstract][Full Text] [Related]
15. Drug resistance among HIV-infected pregnant women receiving antiretrovirals for prophylaxis.
Duran AS; Losso MH; Salomón H; Harris DR; Pampuro S; Soto-Ramirez LE; Duarte G; de Souza RS; Read JS;
AIDS; 2007 Jan; 21(2):199-205. PubMed ID: 17197811
[TBL] [Abstract][Full Text] [Related]
16. High rates of baseline antiretroviral resistance among HIV-infected pregnant women in an HIV referral centre in Rio de Janeiro, Brazil.
de Lourdes Teixeira M; Nafea S; Yeganeh N; Santos E; Gouvea MI; Joao E; Ceci L; Bressan C; Cruz ML; Sidi LC; Nielsen-Saines K
Int J STD AIDS; 2015 Nov; 26(13):922-8. PubMed ID: 25504831
[TBL] [Abstract][Full Text] [Related]
17. Antiretroviral therapeutic drug monitoring in HIV-infected pregnant women: maternal immunovirological outcome at delivery and during the 18 month follow-up period.
Nicastri E; Ivanovic J; Signore F; Tempestilli M; Bellagamba R; Viscione M; Pisani G; Vallone C; Tommasi C; Gallo AL; De Nardo P; Pucillo PL; Narciso P
Curr HIV Res; 2012 Oct; 10(7):606-13. PubMed ID: 22762419
[TBL] [Abstract][Full Text] [Related]
18. Maternal immune responses and risk of infant infection with HIV-1 after a short course Zidovudine in a cohort of HIV-1 infected pregnant women in rural Kenya.
Makokha EP; Songok EM; Orago AA; Koech DK; Chemtai AK; Kobayashi N; Mpoke S; Tukei PM; Andayi FA; Lihana RW; Adungo NI; Vulule JM
East Afr Med J; 2002 Nov; 79(11):567-73. PubMed ID: 12630488
[TBL] [Abstract][Full Text] [Related]
19. Reduction of maternal mortality with highly active antiretroviral therapy in a large cohort of HIV-infected pregnant women in Malawi and Mozambique.
Liotta G; Mancinelli S; Nielsen-Saines K; Gennaro E; Scarcella P; Magid NA; Germano P; Jere H; Guidotti G; Buonomo E; Ciccacci F; Palombi L; Marazzi MC
PLoS One; 2013; 8(8):e71653. PubMed ID: 23990966
[TBL] [Abstract][Full Text] [Related]
20. Human Immunodeficiency Virus (HIV) types Western blot (WB) band profiles as potential surrogate markers of HIV disease progression and predictors of vertical transmission in a cohort of infected but antiretroviral therapy naïve pregnant women in Harare, Zimbabwe.
Duri K; Müller F; Gumbo FZ; Kurewa NE; Rusakaniko S; Chirenje MZ; Mapingure MP; Stray-Pedersen B
BMC Infect Dis; 2011 Jan; 11():7. PubMed ID: 21211021
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
